The cost-effectiveness of high-dose oral proton pump inhibition after endoscopy in the acute treatment of peptic ulcer bleeding

Alimentary Pharmacology & Therapeutics
A N BarkunM Bardou

Abstract

Recent data suggest a role for high-dose oral proton pump inhibition in ulcer bleeding. To compare the cost-effectiveness of oral high-dose proton pump inhibition to both high-dose intravenous proton pump inhibition and placebo administration. The model adopted a 30-day time horizon, and focused on patients with ulcer haemorrhage initially treated endoscopically for high-risk stigmata. Re-bleeding rates were set a priori based on non-head-to-head data from the literature, and charges and lengths of stay from a national American database. Sensitivity analyses were carried across a broad range of clinically relevant assumptions. Re-bleeding rates for patients receiving intravenous, oral, or placebo therapies were 5.9%, 11.8%, and 27%, respectively. The mean lengths of stay and costs for admitted patients with and without re-bleeding were 4.7 and 3 days; $11,802, and $7993, respectively. High-dose intravenous proton pump inhibition was more effective and less costly (dominant) than high-dose oral proton pump inhibition with incremental savings of $136.40 per patient treated. The oral high-dose strategy in turn dominated placebo administration. Results remained robust according to one- and two-way sensitivity analyses. In patients ...Continue Reading

Associated Clinical Trials

Nov 20, 2019·Zeinab Nasr El Din Ahmed

References

Aug 1, 1978·American Journal of Surgery·C ChaimoffM Djaldetti
Feb 1, 1996·The Surgical Clinics of North America·G C Jiranek, R A Kozarek
Apr 10, 1997·The New England Journal of Medicine·M S KhurooJ S Sodi
Apr 1, 1997·Scandinavian Journal of Gastroenterology·A Berstad
Aug 30, 1997·BMJ : British Medical Journal·O BlatchfordJ Pell
Sep 28, 1998·The European Journal of Neuroscience·A R HortonA M Davies
Dec 14, 1999·Alimentary Pharmacology & Therapeutics·A N BarkunR N Fedorak
Jan 15, 2000·Journal of Clinical Gastroenterology·M Bustamante, N Stollman
Mar 29, 2000·Journal of Gastroenterology and Hepatology·Y LiW Yu
Sep 6, 2000·Alimentary Pharmacology & Therapeutics·N M SelbyC J Hawkey
Jun 21, 2001·The Annals of Pharmacotherapy·B L Erstad
Jun 26, 2001·Alimentary Pharmacology & Therapeutics·J P GisbertJ M Pajares
Oct 27, 2001·British Journal of Clinical Pharmacology·J A Goldstein
Jan 17, 2002·The Annals of Pharmacotherapy·P J ZedC A Marra
Mar 5, 2002·Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie·T Michael VallisDes Leddin
Mar 7, 2002·Current Treatment Options in Gastroenterology·Grace H. Elta
May 29, 2002·Alimentary Pharmacology & Therapeutics·J E LevineC W Howden
Jan 16, 2003·The American Journal of Gastroenterology·Brennan M R SpiegelNimish B Vakil
Mar 18, 2003·The Annals of Pharmacotherapy·Rebecca M HugginsJoanne K Latour
Jul 16, 2003·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Yves M GagnonRobert A Enns
Nov 19, 2003·Annals of Internal Medicine·Alan BarkunUNKNOWN Nonvariceal Upper GI Bleeding Consensus Conference Group

❮ Previous
Next ❯

Citations

Nov 14, 2008·Current Gastroenterology Reports·Thomas O G Kovacs
Nov 12, 2009·Current Gastroenterology Reports·Kevin A GhassemiDennis M Jensen
Mar 30, 2007·Current Treatment Options in Gastroenterology·Grigoris I Leontiadis, Colin W Howden
Sep 30, 2006·Nature Clinical Practice. Gastroenterology & Hepatology·James Y W Lau
Oct 9, 2008·Drugs·Thomas O G Kovacs, Dennis M Jensen
May 19, 2009·Gastroenterology Clinics of North America·Grigorios I Leontiadis, Colin W Howden
Feb 29, 2008·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Salman Al-SabahMarc Bardou
Aug 23, 2006·Gastrointestinal Endoscopy·Eduardo B da SilveiraUNKNOWN RUGBE investigators
May 17, 2006·Alimentary Pharmacology & Therapeutics·P O KatzA N Barkun
Sep 10, 2010·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Rutledge Ellis-Behnke
Jan 23, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Alan N BarkunMarc Bardou
Mar 14, 2007·Scandinavian Journal of Gastroenterology·Sven AdamsenPeer Wille-Jørgensen
Dec 25, 2010·Therapeutic Advances in Gastroenterology·Sandy H Pang, David Y Graham
Jun 14, 2013·The Cochrane Database of Systematic Reviews·Ignacio NeumannGrigorios I Leontiadis
May 26, 2005·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Kirill Rivkin, Aleksandr Lyakhovetskiy
Nov 14, 2008·Scandinavian Journal of Gastroenterology·Ole HøieMorgan Stokkeland
May 21, 2005·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·John W Devlin
Jun 28, 2006·Medicina clínica·Javier P Gisbert

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.